| 26/543 |
Privately Owned Residential Properties |
| 26/525 |
Oncology – Myelofibrosis & SCT |
| 26/512 |
Reproductive Care |
| 26/511 |
Trust Bank Spending |
| 26/509 |
Ovarian Cancer Treatments |
| 26/508 |
Capital Spending FY 2026/27 |
| 26/506 |
Unauthorised Access to Patient Records (2021–Present) |
| 26/499 |
Endometrial Cancer Treatments |
| 26/492 |
Wrongful Access of Patient Records FY 2021/22 to 2025/26 |
| 26/491 |
Urothelial Cancer Treatments |
| 26/490 |
Gastric & GOJ Adenocarcinoma Data Request |
| 26/486 |
Hearing Aids |
| 26/485 |
Oncology Gastro Cancer |
| 26/481 |
Lung Cancer Treatments |
| 26/480 |
Dementia Assessment Clinics |
| 26/477 |
AHP & HSS Staffing |
| 26/475 |
Dravet Syndrome & Lennox-Gastaut Syndrome |
| 26/474 |
Diffuse Large B Cell Lymphoma (DLBCL) |
| 26/471 |
Disciplinary Action for Inappropriate Record Access |
| 26/470 |
Portering, Task Dispatch and Location Systems (RXC) |
